MERIT MEDICAL SYSTEMS INC (MMSI)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for MMSI
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MMSI | Independent Director; Former Chief Financial Officer of Biogen, Inc. | 62 | ["B.S. (accounting), Georgetown University", "Director of Baxter International", "Chief Financial Officer of Biogen Inc", "Executive Vice President and Chief Financial Officer of IQVIA Holdings Inc.", "Chief Financial Officer of EchoStar Communications Corporation", "Partner of PricewaterhouseCoopers, LLP"] | ["Audit", "Finance", "C"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BAX | Former Executive Vice President and Chief Financial Officer of Biogen Inc.; Independent Director | 62 | ["Significant financial expertise and corporate leadership experience, including in business transformation, complex refinancing and capital structure optimization, financial management, accounting principles and practices and capital markets transactions", "Meaningful management experience in the global healthcare industry", "Former Executive Vice President and Chief Financial Officer at Biogen Inc.", "Executive Vice President and Chief Financial Officer at IQVIA Holdings Inc.", "Executive Vice President and Chief Financial Officer at Intelsat S.A.", "Executive Vice President, Chief Operating Officer and Chief Financial Officer at MCG Capital Corporation", "Senior Vice President and Chief Financial Officer at EchoStar Communications Corporation", "Spent 14 years at PricewaterhouseCoopers LLP, including four years as a partner.", "Broad industry experience across global biopharmaceuticals and healthcare technology.", "Financial Expertise / Risk Management with more than 35 years of experience.", "Significant experience overseeing mergers and acquisitions and capital funding transactions.", "Extensive experience in talent and leadership development.", "Healthcare Marketing / Delivery", "Manufacturing and R&D", "M&A / Transactional", "former Chief Financial Officer of Biogen Inc."] | ["Audit Committee"] | 2026 |
| IQV | [] | [] | 2025 |
Biography sourced from the proxy statement filing.
Independent Director Age: 61 Director Since: May 2022 Committees: Audit, Finance Other Public Boards: None Education: B.S. (accounting), Georgetown University Term Expires: 2025 Career Highlights Chief Financial Officer of Biogen Inc, a multinational Nasdaq-listed company engaged in discovering, developing, and delivering therapies for people living with serious and complex diseases, 2020 to February 28, 2025. Executive Vice President and Chief Financial Officer of IQVIA Holdings Inc., a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry, 2015 to 2020 Executive Vice President and Chief Financial Officer of Intelsat, a global provider of satellite services, 2008-2015 Chief Operating Officer (2006-2008) and Chief Financial Officer (2004-2008) of MCG Capital Corporation, a publicly-held commercial finance company, 2004 to 2008 Chief Financial Officer of EchoStar Communications Corporation (dba Dish Network), a satellite television provider, 2000 to 2004 Partner of PricewaterhouseCoopers, LLP, 1996 to 2000, other positions, PricewaterhouseCoopers, LLP, 1986-1996 Director of Catalyst Health Solutions, Inc., a publicly-held pharmacy benefits management company, 2005 to 2012 Certified public accountant Qualifications of Particular Relevance to Merit Mr. McDonnell is a financial executive with more than 35 years of experience providing financial and accounting advice and oversight to life science and technology companies and over 24 years serving as a public company CFO. The Board believes Mr. McDonnell s depth of understanding of financial management, accounting principles and practices, capital markets and financing transactions strengthen the Board s oversight of the Company s finance and accounting policies, procedures and practices. The Board also believes Mr. McDonnell s industry experience enables him to contribute to the Board s evaluation and oversight of merger and acquisition and capital funding transactions, as well as the Company s investor relations and shareholder outreach efforts.